Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Stratification Using Genetic Markers of Patients With a History of Pulmonary Embolism Post Total Hip or Total Knee Arthroplasty

NCT03275610 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT03275610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03275610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Stratification Using Genetic Markers of Patients With a History of Pulmonary Embolism Post Total Hip or Total Knee Arthroplasty
Lead sponsor
University of Southern California
Phase
Observational
Overall status
Enrolling by invitation
Start date
April 24, 2017
Completion date
April 23, 2035
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary embolism